Thoracic Surgery With One-lung Ventilation
Conditions
Keywords
One-Lung Ventilation, hyperoxia
Brief summary
High inspired oxygen concentrations (FiO₂) are commonly administered during general anesthesia to prevent hypoxemia. However, excessive oxygen administration may result in hyperoxemia, which has been associated with impaired hypoxic pulmonary vasoconstriction, increased oxidative stress, ventilation-perfusion mismatch, and postoperative pulmonary complications. During one-lung ventilation (OLV) for thoracic surgery, higher FiO₂ is often required because of increased intrapulmonary shunting, making hyperoxemia a frequent occurrence. The Oxygen Reserve Index (ORI) is a noninvasive pulse oximetry-derived parameter that reflects moderate hyperoxemia (PaO₂ approximately 100-200 mmHg) and may facilitate more precise oxygen titration than pulse oximetry alone.
Detailed description
This prospective, randomized, assessor-blinded clinical trial aims to determine whether FiO₂ titration guided by both ORI and peripheral oxygen saturation (SpO₂) reduces the incidence of hyperoxemia compared with conventional SpO₂-guided FiO₂ titration during OLV in patients undergoing thoracic surgery. Participants will be randomly assigned to either an ORI-guided group or a conventional SpO₂-guided group. The primary outcome is the incidence of hyperoxemia (PaO₂ \>125 mmHg) after OLV. Secondary outcomes include SpO₂, ORI, PaO₂, and FiO₂ measured
Interventions
During one-lung ventilation, FiO₂ is adjusted according to both ORI and SpO₂. FiO₂ is titrated to maintain SpO₂ ≥98% while keeping ORI above 0 to minimize hyperoxemia.
During one-lung ventilation, FiO₂ is adjusted according to SpO₂ alone. FiO₂ is titrated to maintain SpO₂ ≥98% according to the institutional standard of care.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged ≥19 years * Scheduled for elective lung surgery requiring one-lung ventilation * Written informed consent
Exclusion criteria
* Severe pulmonary hypertension. * Left ventricular systolic dysfunction. Withdrawal Criteria: * The participant or legally authorized representative requests withdrawal from the study. * An adverse event occurs that precludes continued participation in the study. * The planned surgery or study procedures are not performed (e.g., ORI monitoring is not applied or arterial blood gas analysis is not performed). * Perfusion Index is less than 2 during the study. * A major violation of the inclusion or
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of hyperoxemia during one-lung ventilation | 10 min after initiation of one-lung ventilation during operation | Hyperoxemia is defined as an arterial partial pressure of oxygen (PaO₂) greater than 125 mmHg measured after initiation of one-lung ventilation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Peripheral oxygen saturation (SpO₂) | 10 mins after two-lung ventilation, 10 mins after initiation of one-lung ventilation, and 10 mins after resumption of two-lung ventilation, all time frames are included in anesthesia time | Peripheral oxygen saturation |
| Oxygen Reserve Index (ORI) | 10 mins after two-lung ventilation, 10 mins after initiation of one-lung ventilation, and 10 mins after resumption of two-lung ventilation, all time frames are included in anesthesia time | Oxygen Reserve Index measured during anesthesia. |
| Arterial oxygen tension (PaO₂) | 10 mins after two-lung ventilation, 10 mins after initiation of one-lung ventilation, and 10 mins after resumption of two-lung ventilation, all time frames are included in anesthesia time | Arterial partial pressure of oxygen measured by arterial blood gas analysis. |
| Fraction of inspired oxygen (FiO₂) | 10 mins after two-lung ventilation, 10 mins after initiation of one-lung ventilation, and 10 mins after resumption of two-lung ventilation, all time frames are included in anesthesia time | Fraction of inspired oxygen administered during anesthesia. |
Countries
South Korea